Realizing the potential of plasma genotyping in an age of genotype-directed therapies. (Q39147121)

9 September 2017

Realizing the potential of plasma genotyping in an age of genotype-directed therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

1 reference

5

John V Heymach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

author name string

Jason J Luke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

Geoffrey R Oxnard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

Cloud P Paweletz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

D Ross Camidge

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

David B Solit

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

Bruce E Johnson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

Cell Free DNA Working Group

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

8 August 2014

1 reference

Journal of the National Cancer Institute

9 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

New data on prostate-cancer mortality after PSA screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Considerations in the development of circulating tumor cell technology for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Detection and characterization of carcinoma cells in the blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Liquid biopsy: monitoring cancer-genetics in the blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Liquid biopsies: genotyping circulating tumor DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Amplification of complex gene libraries by emulsion PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Strategic approach to fit-for-purpose biomarkers in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Analysis of circulating tumor DNA to confirm somatic KRAS mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU214

Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction

21 January 2018

1 reference

12 December 2020

Going with the flow: from circulating tumor cells to DNA.

1 reference

12 December 2020

Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.

1 reference

12 December 2020

High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients

1 reference

12 December 2020

Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing

1 reference

12 December 2020

Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro

1 reference

12 December 2020

High T790M detection rate in TKI-naive NSCLC with EGFR sensitive mutation: truth or artifact?

1 reference

12 December 2020

Circulating tumour cells and cell-free DNA as tools for managing breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJU214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6281080&resulttype=core&format=json